The IARS announces the appointment of Dean Andropoulos, MD, M.H.C.M. as the Medical Officer of SmartTots. Dr. Andropoulos is an established clinical researcher, and a board-certified physician in Anesthesiology and Pediatric Anesthesiology. He is Anesthesiologist-in-Chief at Texas Children’s Hospital and Professor, Anesthesiology and Pediatrics, at Baylor College of Medicine. As the Medical Officer of SmartTots, he will help promote and advocate for research to advance and ensure safety of anesthesia in children. He will specifically work with researchers, clinicians, parents and other relevant stakeholders to develop research strategies to address the pressing challenges to understand the effects of anesthetic and sedative agents in the developing brain. He will also work with all stakeholders to support the implementation and dissemination of research results related to all SmartTots-related issues.
- SmartTots funds two new research initiatives!
- Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity.
- Neonatal Exposure to Propofol Interferes with the Proliferation and Differentiation of Hippocampal Neural Stem Cells and the Neurocognitive Function of Rats in Adulthood via the Akt/p27 Signaling Pathway.
- The Role of Epigenetic Modifications in Neurotoxicity Induced by Neonatal General Anesthesia.
- Isoflurane and Sevoflurane Induce Cognitive Impairment in Neonatal Rats by Inhibiting Neural Stem Cell Development Through Microglial Activation, Neuroinflammation, and Suppression of VEGFR2 Signaling Pathway.